DUBLIN - August 11, 2016 - Medtronic plc (MDT), the global leader in medical technology, today announced the U.S. commercial launch of its MiniMed 630G system with SmartGuard technology FDA approved ...

Medical device major Medtronic plc’s MDT MiniMed 630G system with SmartGuard technology – a new insulin pump that facilitates diabetes care – recently won the U.S. FDA (Food and Drug Administration) ...

Medtronic MiniMed insulin pumps are being recalled due to an issue that can lead to incorrect dosing. The affected pumps include the MiniMed 630G and MiniMed 670G. The recall affects 322,055 devices.

Retainer rings on its MiniMed 630G and MiniMed 670G insulin pumps have been breaking, which can lead to a health hazard for users. The retaining ring is responsible for locking the insulin reservoir ...

The FDA announced an international Class 1 recall of 322,005 Medtronic’s MiniMed 600 Series Insulin Pumps that can cause the user to receive an incorrect amount of insulin. According to the recall ...

Medtronic is recalling certain MiniMed 600 Series insulin pumps due to a missing or broken retainer ring that can potentially lead to the under or over delivery of insulin. Medtronic is recalling ...

Medical device major Medtronic plc's ( MDT) MiniMed 630G system with SmartGuard technology - a new insulin pump that facilitates diabetes care - recently won the U.S. FDA (Food and Drug Administration ...

Medtronic plc, the global leader in medical technology, announced the US commercial launch of its MiniMed 630G system with SmartGuard technology FDA approved for the treatment of people with diabetes ...